Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374–80. https://doi.org/10.1056/NEJM200002103420602.
Article CAS PubMed Google Scholar
Greer IA. CLINICAL PRACTICE. Pregnancy complicated by venous thrombosis. N Engl J Med. 2015;373:540–7. https://doi.org/10.1056/NEJMcp1407434.
Article CAS PubMed Google Scholar
Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. Lancet. 2010;375:500–12. https://doi.org/10.1016/S0140-6736(09)60996-X.
Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6:632–7. https://doi.org/10.1111/j.1538-7836.2008.02921.x.
Article CAS PubMed Google Scholar
Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the Puerperium: Green-top Guideline No. 37a. 2015.
Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol. 2011;117:691–703. https://doi.org/10.1097/AOG.0b013e31820ce2db.
O’Shaughnessy F, Donnelly JC, Bennett K, Damkier P, Ainle FN, Cleary BJ. Prevalence of postpartum venous thromboembolism risk factors in an irish urban obstetric population. J Thromb Haemost. 2019;17:1875–85. https://doi.org/10.1111/jth.14568.
James AH. Pregnancy-associated thrombosis. Hematol Am Soc Hematol Educ Program. 2009. https://doi.org/10.1182/asheducation-2009.1.277. 277 – 85.
Kalaitzopoulos DR, Panagopoulos A, Samant S, Ghalib N, Kadillari J, Daniilidis A, Samartzis N, Makadia J, Palaiodimos L. Kokkinidis D G and Spyrou N. Management of venous thromboembolism in pregnancy. Thromb Res. 2022;211:106–13. https://doi.org/10.1016/j.thromres.2022.02.002.
Article CAS PubMed Google Scholar
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016;27:89–94. https://doi.org/10.5830/CVJA-2016-021.
Article PubMed PubMed Central Google Scholar
Abdul Sultan A, Grainge MJ, West J, Fleming KM, Nelson-Piercy C, Tata LJ. Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England. Blood. 2014;124:2872–80. https://doi.org/10.1182/blood-2014-05-572834.
Article CAS PubMed PubMed Central Google Scholar
James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194:1311–5. https://doi.org/10.1016/j.ajog.2005.11.008.
Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium–a register-based case-control study. Am J Obstet Gynecol. 2008;198:233e1–7. https://doi.org/10.1016/j.ajog.2007.08.041.
American College of O and Gynecologists’ Committee. ACOG Practice Bulletin No. 196: thromboembolism in pregnancy. Obstet Gynecol. 2018;132:e1–e17. https://doi.org/10.1097/AOG.0000000000002706.
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and Prevention of thrombosis, 9th ed: american college of chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e691S–e736S. https://doi.org/10.1378/chest.11-2300.
Article CAS PubMed PubMed Central Google Scholar
Pandor A, Daru J, Hunt BJ, Rooney G, Hamilton J, Clowes M, Goodacre S, Nelson-Piercy C, Davis S. Risk assessment models for venous thromboembolism in pregnancy and in the puerperium: a systematic review. BMJ Open. 2022;12:e065892. https://doi.org/10.1136/bmjopen-2022-065892.
Article PubMed PubMed Central Google Scholar
Tritschler T, Kraaijpoel N, Le Gal G, Wells PS. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320:1583–94. https://doi.org/10.1001/jama.2018.14346.
Hu W, Xu D, Li J, Chen C, Chen Y, Xi F, Zhou F, Guo X, Zhao B, Luo Q. The predictive value of D-dimer test for venous thromboembolism during puerperium in women age 35 or older: a prospective cohort study. Thromb J. 2020;18:26. https://doi.org/10.1186/s12959-020-00241-y.
Article CAS PubMed PubMed Central Google Scholar
Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, Gulmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–33. https://doi.org/10.1016/S2214-109X(14)70227-X.
Muhamad N, Abu MA, Kalok AH, Shafiee MN, Shah SA, Ismail NAM. Safety and effectiveness of fondaparinux as a postpartum thromboprophylaxis during puerperium among muslim women: a single centre prospective study. Front Pharmacol. 2022;13:887020. https://doi.org/10.3389/fphar.2022.887020.
Article CAS PubMed PubMed Central Google Scholar
American College of Obstetricians and Gynecologists’ Committee. Thromboembolism in pregnancy; ACOG PRACTICE BULLETIN;number 123. Obstet Gynecol. 2011;e1–e17. https://doi.org/10.1097/AOG.0000000000002706.
Brenner B, Arya R, Beyer-Westendorf J, Douketis J, Hull R, Elalamy I, Imberti D, Zhai Z. Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients. Thromb J. 2019;17:24. https://doi.org/10.1186/s12959-019-0214-8.
Article CAS PubMed PubMed Central Google Scholar
Kotaska A. Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens. BJOG. 2018;125:1109–16. https://doi.org/10.1111/1471-0528.15150.
Article CAS PubMed PubMed Central Google Scholar
Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.CD001689.pub3. CD001689.
Article PubMed PubMed Central Google Scholar
Gassmann N, Viviano M, Righini M, Fontana P, Martinez de Tejada B, Blondon M. Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis. J Thromb Haemost. 2021;19:452–9. https://doi.org/10.1111/jth.15166.
Ge YZ, Zhang C, Cai YQ, Huang HF. Application of the RCOG Risk Assessment Model for evaluating Postpartum venous thromboembolism in Chinese Women: a case-control study. Med Sci Monit. 2021;27:e929904. https://doi.org/10.12659/MSM.929904.
Article PubMed PubMed Central Google Scholar
Lok WY, Kong CW, To. W W K. A local risk score model for venous thromboembolism prophylaxis for caesarean section in chinese women and comparison with international guidelines. Taiwan J Obstet Gynecol. 2019;58:520–5. https://doi.org/10.1016/j.tjog.2019.05.016.
Article CAS PubMed Google Scholar
Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, Kearon C, Schunemann HJ, Crowther M, Pauker SG, Makdissi R, Guyatt GH. Diagnosis of DVT: antithrombotic therapy and Prevention of thrombosis, 9th ed: american college of chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e351S–e418S. https://doi.org/10.1378/chest.11-2299.
Article CAS PubMed PubMed Central Google Scholar
The National Institute for Health and Care Excellence. Guidelines: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing.2020.
Johnson ED, Schell JC, Rodgers GM. The D-dimer assay. Am J Hematol. 2019;94:833–9. https://doi.org/10.1002/ajh.25482.
Wang M, Lu S, Li S, Shen F. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer. Clin Chim Acta. 2013;425:176–80. https://doi.org/10.1016/j.cca.2013.08.006.
Article CAS PubMed Google Scholar
Kovac M, Mikovic Z, Rakicevic L, Srzentic S, Mandic V, Djordjevic V, Radojkovic D, Elezovic I. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2010;148:27–30. https://doi.org/10.1016/j.ejogrb.2009.09.005.
Article CAS PubMed Google Scholar
Gonzalez-Ordonez AJ, Fernandez-Carreira JM, Fernandez-Alvarez CR, Venta Obaya R, Macias-Robles MD. Gonzalez-Franco A and Arias Garcia M A. The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism. Haematologica. 2003;88:1035–43.
van Schouwenburg IM, Mahmoodi BK, Gansevoort RT, Muntinghe FL, Dullaart RP, Kluin-Nelemans HC, Veeger NJ, Meijer K. Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study. Thromb Haemost. 2012;108:923–9. https://doi.org/10.1160/TH12-06-0426.
Article CAS PubMed Google Scholar
Galeano-Valle F, Ordieres-Ortega L, Oblitas CM, Del-Toro-Cervera J, Alvarez-Sala-Walther L, Demelo-Rodriguez P. Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: a narrative review. Int J Mol Sci. 2021;22. https://doi.org/10.3390/ijms22052627.
Saghazadeh A, Hafizi S, Rezaei N. Inflammation in venous thromboembolism: cause or consequence? Int Immunopharmacol. 2015;28:655–65. https://doi.org/10.1016/j.intimp.2015.07.044.
Article CAS PubMed Google Scholar
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111:4902–7. https://doi.org/10.1182/blood-2007-10-116327.
Article CAS PubMed PubMed Central Google Scholar
Wang TF, Wong CA, Milligan PE, Thoelke MS, Woeltje KF, Gage. B F. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis. Thromb Res. 2014;133:25–9. https://doi.org/10.1016/j.thromres.2013.09.011.
留言 (0)